880261-47-2

Basic information

• Product Name: 3-Pyridinecarboxamide, N-[(4-fluorophenyl)methyl]-5-methoxy-6-methyl-4-(phenylmethoxy)-, 1-oxide
• CAS NO: 880261-47-2
• Molecular Formula: C22H21FN2O4
• Molecular Weight: 396.418
• Mol File: 880261-47-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-Pyridinecarboxamide, N-[(4-fluorophenyl)methyl]-5-methoxy-6-methyl-4-(phenylmethoxy)-, 1-oxide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyridinecarboxamide, N-[(4-fluorophenyl)methyl]-5-methoxy-6-methyl-4-(phenylmethoxy)-, 1-oxide(880261-47-2)
• EPA Substance Registry System: 3-Pyridinecarboxamide, N-[(4-fluorophenyl)methyl]-5-methoxy-6-methyl-4-(phenylmethoxy)-, 1-oxide(880261-47-2)

Safety Data

• Hazardous Substances Data: 880261-47-2(Hazardous Substances Data)

Upstream product

• 140-75-0 para-fluorobenzylamine 
• 880261-45-0 N-(4-fluorobenzyl)-4-hydroxy-5-methoxy-6-methylnicotinamide 
• 880261-44-9 5-bromo-N-(4-fluorobenzyl)-4-hydroxy-6-methylnicotinamide 
• 141703-16-4 5-bromo-4-hydroxy-6-methylnicotinic acid 
• 67367-33-3 4-hydroxy-6-methylnicotinic acid 
• 880261-46-1 4-benzyloxy-N-(4-fluorobenzyl)-5-methoxy-6-methylnicotinamide 

Downstream Products

• 880261-48-3 4-benzyloxy-N-[(4-fluorobenzyl)]-6-hydroxymethyl-5-methoxynicotinamide 
• 880261-51-8 methyl 5-{((4-fluorobenzyl)carbamoyl)}-3-methoxy-4-oxo-1,4-dihydropyridine-2-carboxylate 
• 880261-52-9 4-benzyloxy-5-(4-fluorobenzylcarbamoyl)-3-methoxypyridine-2-carboxylic acid 
• 880261-53-0 4-Benzyloxy-3-methoxy-pyridine-2,5-dicarboxylic acid 2-amide 5-(4-fluoro-benzylamide) 
• 1400003-21-5 C₂₃H₂₂FN₃O₄ 
• 1400003-23-7 C₂₄H₂₄FN₃O₄ 
• 880261-49-4 4-benzyloxy-N-(4-fluorobenzyl)-6-formyl-5-methoxynicotineamide 
• 880261-50-7 methyl 4-(benzyloxy)-5-{((4-fluorobenzyl)carbanoyl)}-3-methoxypyridine-2-carboxylate 

Relevant articles and documents

Carbamoyl pyridone HIV-1 integrase inhibitors. 1. Molecular design and establishment of an advanced two-metal binding pharmacophore

Our group has focused on expanding the scope of a two-metal binding pharmacophore concept to explore HIV-1 integrase inhibitors through medicinal chemistry efforts to design novel scaffolds which allow for improvement of pharmacokinetic (PK) and resistanc